Publicaciones (115) Publicaciones de Marta María Alonso Roldán

2024

  1. A road map for the treatment of pediatric diffuse midline glioma

    Cancer Cell

  2. Characterization of immune populations in the tumor microenvironment of diffuse midline glioma orthotopic mouse models by flow cytometry

    STAR Protocols, Vol. 5, Núm. 1

  3. Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice

    Molecular Therapy, Vol. 32, Núm. 3, pp. 722-733

  4. Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study

    The Lancet Regional Health - Europe, Vol. 41

  5. Oncolytic adenoviruses and immunopeptidomics: a convenient marriage

    Molecular Oncology

2023

  1. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

    Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393

  2. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

    Nature Medicine, Vol. 29, Núm. 6, pp. 1370-1378

  3. Oncolytic virotherapy for the treatment of pediatric brainstem gliomas

    Revue Neurologique, Vol. 179, Núm. 5, pp. 475-480

  4. Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 169-188

  5. Promises of oncolytic viral therapy for adult and children with brain glioma

    Current Opinion in Oncology, Vol. 35, Núm. 6, pp. 529-535

  6. TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory

    Cancer Cell, Vol. 41, Núm. 11, pp. 1911-1926.e8

  7. Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology

    Neoplasia (United States), Vol. 42

2022

  1. DNA-damaging cancer cells to improve virotherapy

    Molecular Therapy - Oncolytics

  2. Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

    JCI Insight, Vol. 7, Núm. 7

  3. Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma

    Molecular Therapy - Oncolytics, Vol. 26, pp. 246-264

  4. Immunovirotherapy for Pediatric Solid Tumors: A Promising Treatment That is Becoming a Reality

    Frontiers in Immunology, Vol. 13

  5. Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory

    Molecular Cancer Therapeutics, Vol. 21, Núm. 3, pp. 471-480

  6. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

    New England Journal of Medicine, Vol. 386, Núm. 26, pp. 2471-2481

  7. Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry

    Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 7

  8. The Comparative Experimental Study of Sodium and Magnesium Dichloroacetate Effects on Pediatric PBT24 and SF8628 Cell Glioblastoma Tumors Using a Chicken Embryo Chorioallantoic Membrane Model and on Cells In Vitro

    International Journal of Molecular Sciences, Vol. 23, Núm. 18